Myeloid-Derived Suppressor Cells as a Potential Therapy for Experimental Autoimmune Myasthenia Gravis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Immunology

• Publication date

  2014-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4049/jimmunol.1400857PMID 25057008PMCID PMC4784709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.

  2013cited by this paper
• Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer

  2013cited by this paper
• Myeloid-Derived Suppressor Cells in Murine Retrovirus-Induced AIDS Inhibit T- and B-Cell Responses In Vitro That Are Used To Define the Immunodeficiency

  2012cited by this paper
• Rituximab in refractory and non‐refractory myasthenia: A retrospective multicenter study

  2012cited by this paper
• Experimental Autoimmune Myasthenia Gravis in the Mouse

  2011cited by this paper
• Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice

  2011cited by this paper
• Antigen specificity of immune suppression by myeloid‐derived suppressor cells

  2011cited by this paper
• In vivo suppressive function of myeloid‐derived suppressor cells is limited to the inflammatory site

  2011cited by this paper
• GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis.

  2011cited by this paper
• Editorial: PGE2‐producing MDSC: a role in tumor progression?

  2010cited by this paper
• Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells

  2010cited by this paper
• Antibody effector mechanisms in myasthenia gravis—Pathogenesis at the neuromuscular junction

  2010cited by this paper
• Pivotal Advance: Tumor‐mediated induction of myeloid‐derived suppressor cells and M2‐polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells

  2010cited by this paper
• Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis.

  2009cited by this paper
• Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion

  2009cited by this paper
• Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer 1

  2009cited by this paper
• T-bet deficiency decreases susceptibility to experimental myasthenia gravis.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009influential reference
• B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.

  2008cited by this paper
• C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis.

  2008cited by this paper
• A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

  2008cited by this paper
• Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4

  2008cited by this paper
• NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non–Small Cell Lung Cancer

  2008cited by this paper
• Myasthenia gravis: past, present, and future.

  2006cited by this paper
• NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.

  2006cited by this paper
• Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report.

  2003cited by this paper
• Prostaglandin catabolizing enzymes.

  2002cited by this paper
• Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection.

  2002cited by this paper
• Role of antigen receptor affinity in T cell–independent antibody responses in vivo

  2002cited by this paper
• Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus

  2002cited by this paper
• Mycophenolate mofetil and its mechanisms of action.

  2000cited by this paper
• Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages.

  1999cited by this paper
• FK506 prevents induction of rat experimental autoimmune myasthenia gravis.

  1997cited by this paper
• Nitric oxide synthase inhibitors: amino acids.

  1996influential reference
• NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

  1994influential reference
• Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.

  1987cited by this paper
• The T-cell-independent immune response to the hapten NP uses a large repertoire of heavy chain genes.

  1985influential reference
• Treatment of experimental myasthenia gravis with cyclosporin A.

  1985cited by this paper
• Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.

  1984cited by this paper
• Regulation of human B cell proliferation by prostaglandin E2.

  1984cited by this paper

• Biomarkers in autoimmune myasthenia gravis: A narrative review

  2025cites this paper
• Combined elevation of myeloid-derived suppressor cells and Tregs predicts lymph node metastasis in breast cancer

  2025cites this paper
• Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis

  2025cites this paper
• Characterizing the Emergence of Myeloid‐Derived Suppressor Cell Subsets in a Murine Model of Pulmonary Fibrosis

  2025cites this paper
• Tryptophan-immunoadsorption plasmapheresis regulates polymorphonuclear-myeloid-derived suppressor cells and pro-inflammatory cytokines.

  2024cites this paper
• Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review

  2024cites this paper
• Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies

  2023influential citation
• The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model

  2023cites this paper
• MAGEA1 and hTERT Peptide Treatment Improves the Potency of The Dendritic Cell- Cytotoxic T Lymphocytes (DC-CTL) Immunotherapy in DAC Treated Acute Myeloid Leukemia

  2022cites this paper
• Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease

  2022cites this paper
• Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity

  2022cites this paper
• Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation

  2022cites this paper
• Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy

  2022cites this paper
• Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals

  2022cites this paper
• Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good

  2022cites this paper
• Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells

  2021cites this paper
• Myeloid-derived suppressor cell and regulatory T cell frequencies in canine myasthenia gravis: A pilot study.

  2021cites this paper
• An Inflammatory Loop Between Spleen-Derived Myeloid Cells and CD4+ T Cells Leads to Accumulation of Long-Lived Plasma Cells That Exacerbates Lupus Autoimmunity

  2021cites this paper
• Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.

  2021cites this paper
• Myeloid-derived suppressor cells: Important communicators in systemic lupus erythematosus pathogenesis and its potential therapeutic significance.

  2021cites this paper
• Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.

  2021cites this paper
• Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus

  2021cites this paper
• Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity

  2021cites this paper
• Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)

  2020cites this paper
• Fatty acid transporter 2 reprograms neutrophils in cancer Fatty acid transporter 2 reprograms neutrophils in cancer

  2020cites this paper
• Conjugation of TLR7 Agonist Combined with Demethylation Treatment Improves Whole-Cell Tumor Vaccine Potency in Acute Myeloid Leukemia

  2020cites this paper
• Immunoregulatory Cells in Myasthenia Gravis

  2020cites this paper
• Increased GITRL Impairs the Function of Myeloid-Derived Suppressor Cells and Exacerbates Primary Sjögren Syndrome

  2019cites this paper
• Fatty acid transporter 2 reprograms neutrophils in cancer

  2019cites this paper
• Myeloid‐derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells

  2019cites this paper
• Increased GITRL impairs the function of MDSCs and exacerbates primary Sjögren’s syndrome

  2018cites this paper
• Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease

  2018cites this paper
• Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8+ T cell response.

  2018cites this paper
• Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5

  2018cites this paper
• Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata

  2018cites this paper
• Administration of cytokine-induced myeloid-derived suppressor cells ameliorates renal fibrosis in diabetic mice

  2018cites this paper
• Myeloid-derived suppressor cells control B cell accumulation in the CNS during autoimmunity

  2018cites this paper
• Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases

  2018influential citation
• Biology of Myeloid-Derived Suppressor Cells

  2018cites this paper
• LP-BM5 Retrovirus–Expanded Monocytic Myeloid-Derived Suppressor Cells Alter B Cell Phenotype and Function

  2018cites this paper
• A novel MDSC-induced PD-1−PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties

  2017cites this paper
• GvHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells Running Title: GVHD inflammasome induction in MDSCs

  2017cites this paper
• Myeloid‐derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes

  2017cites this paper
• C-C Chemokine Receptor Type 2–Dependent Migration of Myeloid-Derived Suppressor Cells in Protection of Islet Transplants

  2017cites this paper
• Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death–Ligand 1

  2016cites this paper
• Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.

  2016cites this paper
• Myeloid-derived suppressor cells induce the expansion of regulatory B cells and ameliorate autoimmunity in Roquin san / san mice , one of murine models of SLE Short title : MDSCs ameliorate autoimmunity in a murine model of lupus

  2016cites this paper
• Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β.

  2016cites this paper
• Myeloid‐Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus

  2016cites this paper
• This information is current as Ligand 1 − via Programmed Death Hepatic Stellate Cells Directly Inhibit B Cells

  2016cites this paper
• Understanding autoimmunity: The ion channel perspective.

  2016cites this paper
• Tolerance and immune suppression in the tumor microenvironment.

  2016cites this paper
• Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis

  2016cites this paper
• Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

  2016cites this paper
• Adipose‐derived mesenchymal stromal cells modulate experimental autoimmune arthritis by inducing an early regulatory innate cell signature

  2016cites this paper
• Animal models of myasthenia gravis: utility and limitations

  2016cites this paper
• Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface–Bound Latent TGF-β1/GARP Complex

  2015cites this paper
• Hepatic Stellate Cells Inhibit T Cells through Active TGF-b1 from a Cell Surface–Bound Latent TGF-b1/GARP Complex

  2015cites this paper
• In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity.

  2015cites this paper
• Myeloid-derived suppressor cells in B cell malignancies

  2015cites this paper
• The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity

  2015cites this paper
• Adoptive cell transfer in autoimmune hepatitis

  2015cites this paper
• IMPACT OF L-ARGININE TRANSPORTATION ON MYELOID-DERIVED SUPPRESSOR CELL FUNCTION

  2015cites this paper
• Mouse models of myasthenia gravis.

  2015cites this paper
• Molecular mimicry and clonal deletion: A fresh look.

  2015cites this paper
• GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.

  2015cites this paper
• Hepatic stellate cell-conditioned myeloid cells provide a novel therapy for prevention of factor VIII antibody formation in mice.

  2015cites this paper
• Hepatic immune tolerance induced by hepatic stellate cells.

  2015cites this paper
• GVHD-associated , in fl ammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells

  2015cites this paper